Yamamoto K, Osada H, Seto M, Ogura M, Suzuki H, Utsumi K R, Oyama A, Ariyoshi Y, Nakamura S, Kurita S
Department of Hematology and Chemotherapy, Aichi Cancer Center, Nagoya.
Jpn J Cancer Res. 1992 May;83(5):465-76. doi: 10.1111/j.1349-7006.1992.tb01951.x.
A case of non-Hodgkin's lymphoma showed a phenotypic and genotypic cell lineage switch twice during nine years of his clinical history; first, T-cell type, pleomorphic small cell lymphoma developed, followed by B-cell type, diffuse centroblastic/centrocytic lymphoma, and finally T-zone lymphoma without follicles again developed, from which AST-1 cultured cell line was established. Karyotype analysis demonstrated a shared abnormal chromosome, der(1)t(1;?)(p36;?), among the first relapsed B-cell tumor, the second relapsed T-cell tumor and AST-1 cell line. Furthermore, T-cell receptor (TCR) gamma gene rearrangement bands of the same size were observed in the first relapsed B-cell tumor and the second relapsed T-cell tumor as well as AST-1 cell line. These results suggested that both relapsed tumors of different cell lineages are derived from a common malignant clone, presumably a committed lymphoid stem cell. A unique translocation, t(2;14)(q37;q11.2), which may involve TCR delta/alpha gene complex, was observed in the second relapsed tumor and AST-1 cells. To attempt to isolate the breakpoint of this translocation, the configuration of TCR delta/alpha gene complex was studied. The result showed that two rearrangements of TCR alpha gene detected with J alpha probes were the products of the normal TCR rearrangement process, and were not involved in the translocation at this region. This patient, together with the AST-1 cell line, provided us a unique opportunity to study the development and clonal evolution of malignant lymphoma.
一例非霍奇金淋巴瘤患者在其九年的临床病程中出现了两次表型和基因型细胞系转换;首先,发展为T细胞型多形性小细胞淋巴瘤,随后是B细胞型弥漫性中心母细胞/中心细胞淋巴瘤,最后再次发展为无滤泡的T区淋巴瘤,并由此建立了AST-1培养细胞系。核型分析显示,在首次复发的B细胞肿瘤、第二次复发的T细胞肿瘤和AST-1细胞系中存在一条共同的异常染色体,即der(1)t(1;?)(p36;?)。此外,在首次复发的B细胞肿瘤、第二次复发的T细胞肿瘤以及AST-1细胞系中观察到大小相同的T细胞受体(TCR)γ基因重排带。这些结果表明,不同细胞系的复发肿瘤均源自一个共同的恶性克隆,推测为一个定向的淋巴干细胞。在第二次复发肿瘤和AST-1细胞中观察到一种独特的易位,t(2;14)(q37;q11.2),可能涉及TCRδ/α基因复合体。为了试图分离这种易位的断点,对TCRδ/α基因复合体的结构进行了研究。结果显示,用Jα探针检测到的TCRα基因的两次重排是正常TCR重排过程的产物,不涉及该区域的易位。该患者以及AST-1细胞系为我们研究恶性淋巴瘤的发生发展和克隆进化提供了一个独特的机会。